Evidence Sync
Vendor:
First CVE: Sep 26, 2018 · Active for 7 years
1
Total CVEs
Bottom 1%
1.0
Avg CVEs / Year
Bottom 1%
9.8
Avg CVSS
Higher Avg CVSS than 87% of tracked products
0.0%
KEV Rate
Bottom 1%
Trends Over Time
The number and severity of CVEs published that impact Evidence Sync over time
Volume of CVEsAvg CVSS Base Score
First CVE
Sep 26, 2018
7 years ago
Most Recent CVE
Sep 26, 2018
2,858 days ago
CVE Severity & Scoring
Evidence Sync1 CVEs
100%
All CVEs352,294 CVEs
45%
40%
11%
Critical
Attack Vector
Local0 (0.0%)
Network1 (100.0%)
Unknown0 (0.0%)
Physical0 (0.0%)
Adjacent Network0 (0.0%)
Attack Complexity
Low1 (100.0%)
High0 (0.0%)
Unknown0 (0.0%)
User Interaction
None1 (100.0%)
Unknown0 (0.0%)
Required0 (0.0%)
Privileges Required
Low0 (0.0%)
High0 (0.0%)
None1 (100.0%)
Unknown0 (0.0%)
Top CVEs
Signals from CVEs in this product scope (1 CVEs).
1 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2018-17538CRITICAL Axon (formerly TASER International) Evidence Sync 3.15.89 is vulnerable to process injection. NOTE: the vendor's position is that this CVE is not associated with information that s | Sep 26, 2018 | 9.8 | 31 | NO | NO |
Exploit Exposure
Signals from CVEs in this product scope (1 CVEs).
CISA KEV
0 CVEs
0.0% of CVEs· Bottom 1%
Metasploit
0 CVEs
0.0% of CVEs· Bottom 1%
Nuclei
0 CVEs
0.0% of CVEs· Bottom 1%
ExploitDB
0 CVEs
0.0% of CVEs· Bottom 1%
Social Chatter
Signals from CVEs in this product scope (1 CVEs).
Media Mentions
Signals from CVEs in this product scope (1 CVEs).
Top CNAs Publishing CVEs For Evidence Sync
Versions
| Version | CVE Count | Avg CVSS | Avg EPSS | KEV | Exploits |
|---|---|---|---|---|---|
| 3.15.89 | 1 | 9.8 | 2.5% | 0 | 0 |